Aortic Valve Replacement
31
2
6
13
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.5%
2 terminated out of 31 trials
86.7%
+0.2% vs benchmark
16%
5 trials in Phase 3/4
23%
3 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (31)
Risk Factors of Atrial Fibrillation After Cardiac Surgery
SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
INSPIRIS China PMCF Study
Effects of Aortic Valve Replacement on Myocardial T1 Values in Severe Aortic Valve Stenosis
Optimization Post-TAVR to IMprove Activity Levels (OPTIMAL Study)
CardioLogical Interventions and Acute strOke Treatment sTudy
The Role of 4 Different Consent Approaches on a Pilot Study to Increase Cardiac Rehabilitation Attendance
INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study
Evaluation of Safety and Effectiveness of the EMBLOK EPS Compared With No Cerebral Embolic Protection During TAVR
Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR
Association Between Surgical Aortic Valve Replacement and Long-term Outcomes in 50 to 65-year-olds
Outcomes After Albumin Vs Lactated Ringer's Solution in CABG and AVR Procedures
Serratus Anterior Plane Block for Minimal Invasive Cardiac Surgery
RESILIENCE Trial: Evaluation of the Durability of Aortic Bioprostheses/Valves With RESILIA Tissue in Subjects Under 65
Prospective Evaluation of the Quality of Life of Elderly Patients Undergoing Transfemoral Percutanous Aortic Valve Replacement (TAVI) for the Treatment of Severe Aortic Stenosis.
Safety and Effectiveness Study of Perceval S Valve for Extended CE Mark
Apixaban for the Prevention of Latent Biological Valve Thrombosis
Transcatheter Aortic Prosthesis Function: A Long-term Follow-up Study
PERCEVAL Pivotal Trial
Innovative Device for Pain Management by Millimeter Band Radiation: Electronic-Pain Killer